Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -238.85%.
GROSS MARGIN
N/A
GROSS MARGIN AVG TTM
-98.06%
GROSS MARGIN AVG 3Y
94.52%
GROSS MARGIN AVG 5Y
60.41%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CytoMed Therapeutics Limited
Market Cap
$11.95M
Gross Margin
N/A
TTM Avg
-98.06%
3Y Avg
94.52%
5Y Avg
60.41%
Market Cap
$11.94M
Gross Margin
36.23%
TTM Avg
36.65%
3Y Avg
39.59%
5Y Avg
41.13%
Market Cap
$12.46M
Gross Margin
71.61%
TTM Avg
70.70%
3Y Avg
67.95%
5Y Avg
69.37%
Market Cap
$11.42M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.63M
Gross Margin
-137.55%
TTM Avg
-73123.88%
3Y Avg
-36779.95%
5Y Avg
-24519.97%
Market Cap
$11.21M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
-4489.78%
Market Cap
$11.01M
Gross Margin
18.76%
TTM Avg
9.38%
3Y Avg
50.69%
5Y Avg
33.79%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $11.95M | N/A | -98.06% | 94.52% | 60.41% |
| IRIDEX Corporation (IRIX)vs › | $11.94M | 36.23% | 36.65% | 39.59% | 41.13% |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | 71.61% | 70.70% | 67.95% | 69.37% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | 84.45% | 64.39% | 56.15% | 53.94% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | -137.55% | -73123.88% | -36779.95% | -24519.97% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | 0.00% | 50.00% | 25.00% | -4489.78% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | 18.76% | 9.38% | 50.69% | 33.79% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | 89.58% | 88.41% | -34.57% | -154.89% |
Gross Margin
N/A
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -238.85% |
| 2025-12-31 | -330.85% |
| 2025-09-30 | 84.40% |
| 2025-06-30 | 93.07% |
| 2025-03-31 | 93.07% |
| 2024-12-31 | 174.87% |
| 2024-09-30 | 89.67% |
| 2024-06-30 | 99.02% |
| 2024-03-31 | 99.01% |
| 2023-12-31 | 98.94% |
| 2023-09-30 | 98.94% |
| 2023-06-30 | -44.62% |
| 2023-03-31 | 97.85% |
| 2022-12-31 | 98.28% |
| 2022-09-30 | 98.27% |
| 2022-06-30 | -156.47% |
| 2022-03-31 | 94.99% |
| 2021-12-31 | -127.84% |
| 2021-09-30 | 95.88% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 84.43% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
